A clinically grounded breakdown of who Ro is genuinely best suited for, covering GLP-1 weight loss, ED, hair loss, and mental health, with real costs, prescribing scope, and head-to-head comparisons.
An independent breakdown of Seed DS-01 probiotic pricing, subscription costs, clinical evidence quality, and how it compares to cheaper alternatives. prepared by the HealthRX.com Editorial Team.
An independent review of Sequence's (now WeightWatchers Clinic) safety record, regulatory compliance, and prescribing practices, with a plain accounting of what is verified, what is plausible, and what still needs confirmation.
An independent, evidence-based analysis of Strut Health's telehealth model, prescribing practices, pricing, and how it compares to alternatives for men's hair loss, ED, and peptides.
An independent breakdown of Superpower's subscription costs, what you actually get, how it compares to alternatives, and whether the price makes clinical sense.
An independent clinical review of Talkspace's safety record, regulatory compliance, licensing standards, prescribing practices, and how it compares with alternative teletherapy platforms.
An evidence-based review of Talkspace's clinical limitations, prescribing scope, cost structure, and where the platform falls short compared to in-person and alternative telehealth care.
An evidence-based review of Thirty Madison's safety track record, regulatory posture, prescribing practices, and how its subsidiary brands (Keeps, Cove, Facet, Erewhon) compare to alternatives for hair loss, migraine, and sexual health.
A critical look at Thrive Cause compounded peptide outcomes, real customer experiences, cost, safety, and how it compares to FDA-approved alternatives.
An independent clinical analysis of TrimRx, the compounded GLP-1 telehealth brand. We examine what the evidence actually shows, where oversight falls short, and how TrimRx compares to FDA-approved alternatives.
An evidence-based critical analysis of Truepill's B2B telehealth pharmacy model, its clinical gaps, regulatory history, and how it compares to direct-care alternatives for patients seeking hormone therapy, GLP-1s, and other medications.
An independent clinical review of Twenty-Eight Health's prescription intake process, contraceptive options, cost structure, insurance coverage, and how it compares to alternatives for reproductive healthcare.
An independent, data-driven review of 1st Optimal's pricing history and trajectory, covering concierge TRT, peptide, and hormone therapy costs, complaint records, and how to evaluate whether this brand is legitimate.
A critical, evidence-based review of 1st Optimal telehealth. Learn which patient profiles should avoid this cash-pay concierge hormone and peptide clinic, what the complaints reveal, and how to verify any telehealth prescriber's legitimacy.
A detailed, evidence-based look at 9amHealth's pricing history, insurance model, GLP-1 access, and whether the platform is legitimate, with primary-source citations throughout.
An independent breakdown of 9amHealth's diabetes and GLP-1 telehealth platform, covering which patient profiles are poor fits, what the evidence says, and how to evaluate whether this service is right for you.
An independent, evidence-based review of Allara Health's medical leadership, clinical credentials, provider licensing, and patient safety record for PCOS care.
An independent, evidence-based review of Alloy Women's Health complaint patterns, BBB standing, FDA regulatory status, and what real consumer reports reveal about this D2C menopause HRT telehealth brand.
An independent, evidence-based review of Alloy Women's Health prescribing patterns, outcomes signals, regulatory standing, and complaint data, with primary-source citations throughout.
An independent, evidence-based review of Alpha Medical's prescribing patterns, GLP-1 outcomes data, legitimacy signals, and complaint history, with primary-source citations throughout.
An independent review of Alto Pharmacy's BBB rating, complaint patterns, state licensing status, and what real consumer feedback reveals about this online specialty pharmacy.
An independent, evidence-based review of Alto Pharmacy's prescribing data signals, legitimacy, complaint patterns, and what the available evidence says about outcomes for specialty and maintenance medication users.
A detailed, independently researched look at Alto Pharmacy's pricing history, cost trajectory, insurance model, and complaints, with primary-source citations and a clinical framework for evaluating whether Alto is right for your prescriptions.
An independent, critical review of Alto Pharmacy covering the patient profiles most likely to have a poor experience, what the data and complaints show, and when to choose a different pharmacy.
An independent, clinically rigorous review of Amazon Pharmacy's medical leadership, licensing, accreditation, complaint record, and legitimacy, with primary-source citations throughout.
A guide to which patient profiles should avoid Amazon Pharmacy, covering controlled substances, cold-chain drugs, urgent needs, and insurance edge cases, with primary-source citations throughout.
An independent review of Amble's LegitScript status, state board standing, FDA compliance, BBB record, and accreditation for women's weight loss and GLP-1 telehealth services.
AG1 Athletic Greens is not right for everyone. Learn which patient profiles face real risks from its high-dose vitamins, heavy metals, and herb-drug interactions, with citations to FDA, NIH, and peer-reviewed sources.
A critical, evidence-based review of Belmar Pharmacy's compounded BHRT products, including the specific patient profiles who should not use this pharmacy, regulatory red flags, and safer alternatives.
BetterHelp is a legitimate teletherapy subscription service, but it is the wrong choice for patients in crisis, those needing psychiatric prescribing, or anyone with severe mental illness. Learn which profiles to avoid BetterHelp and what to use instead.
An independent analysis of Bosley's prescribing practices, clinical outcomes data, complaint history, and regulatory standing for hair restoration treatments including finasteride, minoxidil, and PRP.
A clinical and consumer-protection review of Bosley hair restoration, who is a poor candidate, what the evidence says about its treatments, and how to evaluate whether it is a legitimate option for your hair loss.
An in-depth, evidence-based look at Brightside Health's BBB rating, verified consumer complaints, regulatory standing, and what the data means for patients seeking online mental health care.
An evidence-based, critical review of Brightside Health's prescribing patterns, outcomes data, patient complaints, and legitimacy signals for depression and anxiety treatment.
An independent, clinically grounded review of Brightside Health, who the platform serves well, which patient profiles should look elsewhere, and what the evidence says about its safety, legitimacy, and complaint record.
An independent, data-driven review of Calibrate's GLP-1 weight-loss telehealth platform. We examine prescribing patterns, reported outcomes, complaints, regulatory signals, and what that means for patients considering the service.
An independent, evidence-grounded look at Capsule pharmacy's prescribing data, patient outcomes signals, complaint record, and legitimacy. prepared by the HealthRX.com Editorial Team.
An independent, clinically-grounded review of Capsule pharmacy covering which patient profiles should avoid it, legitimacy concerns, complaint patterns, and regulatory standing.
An independent clinical review of Care/of personalized supplements, covering which patient profiles should avoid the brand, safety concerns, regulatory status, and what verified research actually says about its ingredient formulations.
An independent, data-driven review of Cost Plus Drugs complaints filed with the BBB, state pharmacy boards, and the FDA, plus an analysis of whether the pharmacy is legitimate and safe for patients.
An independent, evidence-based review of Cost Plus Drugs' medical leadership, pharmacy credentials, regulatory standing, and operational transparency. prepared by the HealthRX.com Editorial Team.
An evidence-based, critical review of Cost Plus Drugs: what prescribing data and outcomes signals actually show, what complaints reveal, and how to assess whether the pharmacy is legit for your patients.
Cost Plus Drugs offers steep generic discounts, but certain patient profiles face real risks: no insurance coordination, cold-chain gaps, limited clinical oversight, and formulary blind spots. Learn who should avoid it and why.
An independent review of Curex BBB ratings, consumer complaints, regulatory standing, and GLP-1 prescribing practices, with primary-source citations throughout.
An independent, data-driven look at Defy Medical's BBB rating, consumer complaints, state licensing, FDA oversight, and LegitScript status for TRT, peptides, and hormone therapy.
An independent review of Done's ADHD telehealth platform covering prescribing patterns, regulatory complaints, outcomes signals, and how it compares to evidence-based ADHD care standards.
An independent, evidence-grounded look at Elektra Health's BBB standing, consumer complaint patterns, clinical legitimacy, and how its menopause-care model compares with published guidelines.
An independent review of Emerge telehealth's BBB rating, complaint history, regulatory standing, and GLP-1 prescribing practices, with primary-source citations for every claim.
An independent, evidence-based review of Evernow's BBB rating, consumer complaint patterns, regulatory standing, and clinical quality benchmarks for women seeking menopause telehealth care.
A critical, evidence-based review of Evernow menopause telehealth. Learn which patient profiles face real safety or care-quality risks, what complaints reveal, and how to decide if Evernow is right for you.
An independent review of Found's LegitScript status, state pharmacy board compliance, BBB rating, FDA regulatory standing, and patient complaint history for its GLP-1 telehealth weight-loss program.
An independent, evidence-grounded review of Function Health's BBB rating, consumer complaints, regulatory standing, and what prospective members should know before subscribing.
An independent, evidence-based review of Function Health's medical leadership, physician credentials, lab accreditation, and regulatory standing. Includes BBB status, LegitScript data, and what prospective subscribers should verify before signing up.
An independent review of Function Health's lab-subscription and prescription model, examining prescribing transparency, outcomes data, regulatory standing, and what patients should verify before signing up.
A clinical review of Function Health's lab-subscription model, the patient profiles most likely to be harmed or underserved, and what independent data say about safety, legitimacy, and regulatory standing.
An independent, clinically grounded review of FuturHealth's GLP-1 weight-loss program, including patient profiles who should not use the service, red flags, safety considerations, and how to verify telehealth legitimacy.
An evidence-based, critical look at Gennev's medical leadership, clinician credentials, regulatory standing, and complaint record, with primary-source citations throughout.
An independent, data-driven look at Gennev's prescribing patterns, clinical outcomes signals, patient complaints, and legitimacy as a menopause telehealth platform. prepared by the HealthRX.com Editorial Team.
GoodRx is not right for every patient. Learn which specific patient profiles should avoid GoodRx for prescription discounts, why the savings may be smaller than advertised, and what safer alternatives exist.
An independent, evidence-based review of Hallandale Pharmacy complaint trends, BBB standing, FDA inspection history, and state board actions for patients considering compounded peptides or HRT.